Exact Sciences plans to seek approval soon of an updated Cologuard stool-based colon cancer screening test and launch a blood test to detect cancer that can linger after surgery.
The Madison-based company is also developing blood tests to screen for colon cancer and for many types of cancer at once. But whether it starts a large, expensive study of its multi-cancer screening test next year could depend on whether Congress tells Medicare to pay for it.